Identification of saturated and unsaturated fatty acids released during microsomal incubations

References

• Adas F, Berthou F, Salaun JP, et al. (1999). Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A. Toxicol Lett 1110:43–55
   Google Scholar
• Argikar UA. (2012). Unusual glucuronides. Drug Metab Dispos 40:1239–51
   PubMed Web of Science ®Google Scholar
• Argikar UA, Remmel RP. (2009). Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10. Drug Metab Dispos 37:229–36
   PubMed Web of Science ®Google Scholar
• Bhattacharya AA, Grune T, Curry S. (2000a). Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303:721–32
   PubMed Web of Science ®Google Scholar
• Bhattacharya AA, Curry S, Franks NP. (2000b). Binding of the general anesthetics propofol and halothane to human serum albumin. J Biol Chem 275:38731–8
   PubMed Web of Science ®Google Scholar
• Catala A, Cerruti A. (1997). Non-enzymatic peroxidation of lipids isolated from rat liver microsomes, mitochondria and nuclei. Int J Biochem Cell Biol 29:541–6
   PubMedGoogle Scholar
• Court MH, Krishnaswamy S, Hao Q, et al. (2003). Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31:1125–33
   PubMed Web of Science ®Google Scholar
• Draper AJ, Hammock BD. (2000). Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase. Arch Biochem Biophys 376:199–205
   PubMed Web of Science ®Google Scholar
• Gill KL, Houston JB, Galetin A. (2012). Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney microsomes: comparison with liver and intestinal glucuronidation and impact of albumin. Drug Metab Dispos 40:825–35
   PubMed Web of Science ®Google Scholar
• Gunduz M, Argikar UA, Baeschlin D, et al. (2010). Identification of a novel N-carbamoyl glucuronide: in vitro, in vivo, and mechanistic studies. Drug Metab Dispos 38:361–7
   PubMed Web of Science ®Google Scholar
• Itoh F, Minamide Y, Horie T, Awazu S. (1989). Time dependent changes occurring in rat liver microsomes upon lipid peroxidation. Lipids 24:905–8
   PubMedGoogle Scholar
• Kapitulnik J, Weil E, Rabinowitz R, Krausz MM. (1987). Fetal and adult human liver differ markedly in the fluidity and lipid composition of their microsomal membranes. Hepatology 7:55–60
   PubMed Web of Science ®Google Scholar
• Kerwin JL, Wiens AM, Ericsson LH. (1996). Identification of fatty acids by electrospray mass spectrometry and tandem mass spectrometry. J Mass Spectrom 31:184–92
   PubMedGoogle Scholar
• Kornbrust DJ, Mavis RD. (1980). Relative susceptibility of microsomes from lung, heart, liver, kidney, brain and testes to lipid peroxidation: correlation with vitamin E content. Lipids 15:315–22
   PubMed Web of Science ®Google Scholar
• Lee SH, Pettinella C, Blair IA. (2006). LC/ESI/MS analysis of saturated and unsaturated fatty acids in rat intestinal epithelial cells. Curr Drug Metab 7:929–37
   PubMedGoogle Scholar
• Li X, Franke AA. (2011). Improved LC-MS method for the determination of fatty acids in red blood cells by LC-Orbitrap MS. Anal Chem 83:3192–8
   PubMed Web of Science ®Google Scholar
• Okita RT, Okita JR. (2001). Cytochrome P450 4A fatty acid omega hydroxylases. Curr Drug Metab 2:265–81
   PubMed Web of Science ®Google Scholar
• Rowland A, Elliot DJ, Williams JA, et al. (2006). In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction. Drug Metab Dispos 34:1055–62
   PubMed Web of Science ®Google Scholar
• Rowland A, Gaganis P, Elliot DJ, et al. (2007). Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation. J Pharmacol Exp Ther 321:137–47
   PubMed Web of Science ®Google Scholar
• Rowland A, Elliot DJ, Knights KM, et al. (2008). The “Albumin Effect” and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9. Drug Metab Dispos 36:870–7
   PubMed Web of Science ®Google Scholar
• Rudolph MC, Maluf NK, Wellberg EA, et al. (2012). Mammalian fatty acid synthase activity from crude tissue lysates tracing 13C-labeled substrates using gas-chromatography-mass spectrometry. Anal Biochem 428:158–66
   PubMedGoogle Scholar
• Rustan AC, Drevon CA. (2005) Fatty acids: structures and properties. Encyclopedia of Life Sciences. Published online: 23 September 2005. Available from: http://onlinelibrary.wiley.com/doi/10.1038/npg.els.0003894/full [last accessed 10 Jan 2014]. DOI: 10.1038/npg.els.0003894
   Google Scholar
• Tsoutsikos P, Miners JO, Stapleton A, et al. (2004). Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochem Pharmacol 67:191–9
   PubMed Web of Science ®Google Scholar
• Waskell L, Koblin D, Canova-Davis E. (1982). The lipid composition of human liver microsomes. Lipids 17:317–20
   PubMedGoogle Scholar
• Wattanachai N, Tassaneeyakul W, Rowland A, et al. (2012). Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance. Drug Metab Dispos 40:982–9
   PubMed Web of Science ®Google Scholar
• Yang WC, Adamec J, Regnier FE. (2007). Enhancement of the LC/MS analysis of fatty acids through derivatization and stable isotope coding. Anal Chem 79:5150–7
   PubMedGoogle Scholar